Company / Assets per Share
UroGen Pharma Ltd. Assets per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$4.75
FY2025
5-year range
$4.75 / $8.79
FY2021-FY2025
Trend
-46.0%
vs FY2024
Sector context
#150 of 210
Health Care
What the data says
At $4.75, UroGen Pharma Ltd.'s assets per share ranks #150 of 210 in the Health Care sector. Assets per Share has fluctuated over the past 9 years, ranging from $4.75 in FY2025 to $12.48 in FY2019.
Based on SEC 10-K filings.
4.75 in FY2025 with a 5-year CAGR of -3.9%.
Declined from $7.71 to $4.75 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -7.7%
- 5-Year CAGR
- -3.9%
- 10-Year CAGR
- -
Sector benchmark
#150 of 210 in Health CareTop 71% of 210This company $4.75 Sector average $353.15
▼
-98.7% below sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 46.0% year-over-year.
- Ranks #150 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.09 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.75 | -46.0% |
| FY2024 | $8.79 | +14.1% |
| FY2023 | $7.71 | +27.7% |
| FY2022 | $6.04 | +11.8% |
| FY2021 | $5.40 | -6.9% |
| FY2020 | $5.80 | -53.5% |
| FY2019 | $12.48 | +65.7% |
| FY2018 | $7.53 | -3.1% |
| FY2017 | $7.78 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026